4//SEC Filing
Eltoukhy Helmy 4
Accession 0001752968-25-000007
CIK 0001576280other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 8:01 PM ET
Size
13.6 KB
Accession
0001752968-25-000007
Insider Transaction Report
Form 4
Eltoukhy Helmy
DirectorCo-Chief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-10-01+23,997→ 2,149,870 total - Exercise/Conversion
Restricted Stock Units
2025-10-01−23,997→ 119,986 totalExercise: $0.00→ Common Stock (23,997 underlying) - Tax Payment
Common Stock
2025-10-01$62.65/sh−12,162$761,949→ 2,137,708 total - Exercise/Conversion
Common Stock
2025-09-30+4,814→ 2,128,313 total - Exercise/Conversion
Restricted Stock Units
2025-09-30−4,814→ 4,815 totalExercise: $0.00→ Common Stock (4,814 underlying) - Tax Payment
Common Stock
2025-09-30$62.48/sh−2,440$152,451→ 2,125,873 total
Footnotes (4)
- [F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- [F2]This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.
- [F3]Not applicable for Restricted Stock Units.
- [F4]This represents a restricted stock unit award granted on March 18, 2024 that vests over a three year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period.
Documents
Issuer
Guardant Health, Inc.
CIK 0001576280
Entity typeother
Related Parties
1- filerCIK 0001752968
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 8:01 PM ET
- Size
- 13.6 KB